These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3283198)
61. Off-label use of second-generation antipsychotic agents among elderly nursing home residents. Kamble P; Sherer J; Chen H; Aparasu R Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817 [TBL] [Abstract][Full Text] [Related]
62. On drug usage in nursing homes. Kashgarian M Am J Public Health; 1980 Nov; 70(11):1217-8. PubMed ID: 7425200 [No Abstract] [Full Text] [Related]
63. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders. Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105 [TBL] [Abstract][Full Text] [Related]
64. PRN medication for psychiatric inpatients. Craven JL; Voore PM; Voineskos G Can J Psychiatry; 1987 Apr; 32(3):199-203. PubMed ID: 2882833 [TBL] [Abstract][Full Text] [Related]
65. Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study. Nygaard HA; Ruths S; Straand J; Naik M Aging Clin Exp Res; 2004 Aug; 16(4):277-82. PubMed ID: 15575121 [TBL] [Abstract][Full Text] [Related]
66. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study. Baker JA; Lovell K; Harris N Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059 [TBL] [Abstract][Full Text] [Related]
67. A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home. Lantz MS; Giambanco V; Buchalter EN Psychiatr Serv; 1996 Sep; 47(9):951-5. PubMed ID: 8875659 [TBL] [Abstract][Full Text] [Related]
68. Drug misuse in nursing homes: an institutional addiction? Waxman HM; Klein M; Carner EA Hosp Community Psychiatry; 1985 Aug; 36(8):886-7. PubMed ID: 4029917 [No Abstract] [Full Text] [Related]
69. Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. O'Connor DW; Griffith J; McSweeney K Int Psychogeriatr; 2010 Nov; 22(7):1149-53. PubMed ID: 20199701 [TBL] [Abstract][Full Text] [Related]
70. Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes. Wei YJ; Simoni-Wastila L; Zuckerman IH; Huang TY; Brandt N; Moyo P; Lucas JA J Am Geriatr Soc; 2014 Aug; 62(8):1490-504. PubMed ID: 25041166 [TBL] [Abstract][Full Text] [Related]
71. Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors. Smeets CHW; Gerritsen DL; Zuidema SU; Teerenstra S; van der Spek K; Smalbrugge M; Koopmans RTCM Aging Ment Health; 2018 Sep; 22(9):1239-1246. PubMed ID: 28726490 [TBL] [Abstract][Full Text] [Related]
73. Does the context matter? Utilization of sedative drugs in nursing homes--a multilevel analysis. Sonntag A; Matschinger H; Angermeyer MC; Riedel-Heller SG Pharmacopsychiatry; 2006 Jul; 39(4):142-9. PubMed ID: 16871469 [TBL] [Abstract][Full Text] [Related]
74. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Azermai M; Elseviers M; Petrovic M; Van Bortel L; Vander Stichele R Hum Psychopharmacol; 2011 Jan; 26(1):12-20. PubMed ID: 21394786 [TBL] [Abstract][Full Text] [Related]
75. Changes in psychotropic medication use in nursing homes over a 9-month period. Snowdon J; Vaughan R J Qual Clin Pract; 1997 Jun; 17(2):83-90. PubMed ID: 9178213 [TBL] [Abstract][Full Text] [Related]
76. Prescribing of psychotropic medication by primary care physicians and psychiatrists. Beardsley RS; Gardocki GJ; Larson DB; Hidalgo J Arch Gen Psychiatry; 1988 Dec; 45(12):1117-9. PubMed ID: 2904248 [TBL] [Abstract][Full Text] [Related]
77. [Consumption of psychopharmaceuticals by residents at nursing homes. Significance of the environment at the nursing home]. Hasle H; Olsen RB Ugeskr Laeger; 1989 May; 151(21):1313-6. PubMed ID: 2734920 [TBL] [Abstract][Full Text] [Related]
78. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. Maust DT; Langa KM; Blow FC; Kales HC Int J Geriatr Psychiatry; 2017 Feb; 32(2):164-174. PubMed ID: 26889640 [TBL] [Abstract][Full Text] [Related]
79. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States. Houghton R; Ong RC; Bolognani F Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809 [TBL] [Abstract][Full Text] [Related]